# HIV - Monotherapy in Switzerland (MOST-ch)

> **NCT00531986** · PHASE4 · TERMINATED · sponsor: **Cantonal Hospital of St. Gallen** · enrollment: 60 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Lopinavir-Monotherapy
- **DRUG:** HAART

## Key facts

- **NCT ID:** NCT00531986
- **Lead sponsor:** Cantonal Hospital of St. Gallen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-01
- **Primary completion:** 2008-09
- **Final completion:** 2008-12
- **Target enrollment:** 60 (ACTUAL)
- **Why stopped:** Unexpectedely high rates of treatment-failure
- **Last updated:** 2018-07-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00531986

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00531986, "HIV - Monotherapy in Switzerland (MOST-ch)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00531986. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*